LY-307,452
 |
|
|---|---|
| Systematic (IUPAC) name | |
| (2S,4S)-2-amino-4-(4,4-diphenylbut-1-yl)pentan-1,5-dioic acid | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| ATC code | ? |
| PubChem | CID 6324634 |
| Chemical data | |
| Formula | C21H25NO4 |
| Mol. mass | 355.428 g/mol |
|
|
 (what is this?) (verify) |
|
LY-307,452 is a drug used in neuroscience research, which was among the first compounds found that acts as a selective antagonist for the group II metabotropic glutamate receptors (mGluR2/3),[1] and was useful in early studies of this receptor family,[2][3] although it has largely been replaced by newer drugs such as LY-341,495.
References
- ^ Wermuth CG, Mann A, Schoenfelder A, Wright RA, Johnson BG, Burnett JP, Mayne NG, Schoepp DD (February 1996). "(2S,4S)-2-amino-4-(4,4-diphenylbut-1-yl)-pentane-1,5-dioic acid: a potent and selective antagonist for metabotropic glutamate receptors negatively linked to adenylate cyclase". Journal of Medicinal Chemistry 39 (4): 814–6. doi:10.1021/jm9508144. PMID 8632404.
- ^ Li XC, Beart PM, Monn JA, Jones NM, Widdop RE (October 1999). "Type I and II metabotropic glutamate receptor agonists and antagonists evoke cardiovascular effects after intrathecal administration in conscious rats". British Journal of Pharmacology 128 (3): 823–9. doi:10.1038/sj.bjp.0702850. PMC 1571690. PMID 10516668.
- ^ Sung KW, Choi S, Lovinger DM (November 2001). "Activation of group I mGluRs is necessary for induction of long-term depression at striatal synapses". Journal of Neurophysiology 86 (5): 2405–12. PMID 11698530.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
